| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 22.26B | 23.08B | 18.91B | 32.97B | 41.82B | 11.16B |
| Gross Profit | 4.84B | 3.63B | 2.05B | 4.51B | 20.70B | 4.44B |
| EBITDA | 4.60B | 4.77B | 71.69M | 6.92B | 23.69B | 6.40B |
| Net Income | 3.25B | 1.61B | -2.07B | 4.95B | 20.50B | 5.23B |
Balance Sheet | ||||||
| Total Assets | 118.87B | 113.26B | 100.83B | 91.70B | 79.16B | 39.06B |
| Cash, Cash Equivalents and Short-Term Investments | 10.85B | 8.56B | 5.96B | 9.55B | 10.13B | 6.61B |
| Total Debt | 29.05B | 26.52B | 24.75B | 22.16B | 12.79B | 6.38B |
| Total Liabilities | 65.69B | 61.42B | 53.24B | 39.38B | 30.29B | 12.89B |
| Stockholders Equity | 46.46B | 45.15B | 41.78B | 47.03B | 44.04B | 21.89B |
Cash Flow | ||||||
| Free Cash Flow | 156.41M | -4.48B | -3.39B | -8.50B | 7.54B | -792.97M |
| Operating Cash Flow | 6.03B | 2.94B | 5.16B | 146.48M | 12.49B | 2.62B |
| Investing Cash Flow | -4.03B | -4.41B | -12.24B | -10.18B | -15.31B | -6.18B |
| Financing Cash Flow | 3.34B | 3.72B | 3.45B | 10.22B | 6.40B | 7.13B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$21.23B | 10.18 | 11.90% | 0.98% | 1.21% | 108.04% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | HK$1.12B | 18.52 | 2.55% | 3.52% | 1.20% | -7.22% | |
59 Neutral | HK$1.24B | 7.69 | 7.36% | 2.20% | -7.41% | 65.65% | |
57 Neutral | HK$195.91B | 18.18 | 8.78% | 0.29% | 22.09% | ― | |
55 Neutral | HK$6.10B | 8.07 | 7.70% | ― | -5.68% | -25.13% | |
42 Neutral | HK$13.59B | 154.69 | 0.46% | 1.16% | -17.38% | 224.44% |